Optas LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Optas LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$264K	Sell	1,394 -153	-10%	-$26.7K	0.04%	351
2025 Q4	$263K	Buy	+1,547	New	+$237K	0.04%	343

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Optas LLC's JAZZ Position: Q1 2026 in Review

Optas LLC reduced its Jazz Pharmaceuticals (JAZZ) stake by 9.9% in Q1 2026, selling an estimated $26.7K and leaving 1,394 shares worth $264K. The position accounts for 0.04% of the portfolio, ranked #351.

Optas LLC first reported a position in JAZZ in Q4 2025 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Optas LLC held 1,394 shares of Jazz Pharmaceuticals worth $264K as of Q1 2026.
Optas LLC sold 153 Jazz Pharmaceuticals shares in Q1 2026, an estimated $26.7K.
Jazz Pharmaceuticals made up 0.04% of Optas LLC's portfolio in Q1 2026, its #351 holding.
Optas LLC first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Optas LLC's 13F filing for Q1 2026, filed 27 Apr 2026.